Transplantation, Homologous

• 

  Subject Areas on Research

  • 'Chimeric' grafts assembled from multiple allodisparate donors enjoy enhanced transplant survival. 
  • 5-Azacitidine Monotherapy Followed by Related Haploidentical Hematopoietic Stem Cell Transplantation Achieves Durable Remission in a Pediatric Patient With Acute Undifferentiated Leukemia Refractory to High-Dose Chemotherapy. 
  • A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance). 
  • A comparative study of bovine pericardium (periguard) and homologous sclera as lower eyelid spacer graft analogs in New Zealand white rabbits. 
  • A comparison of murine T-cell-depleted adult bone marrow and full-term fetal blood cells in hematopoietic engraftment and immune reconstitution. 
  • A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C. 
  • A device to facilitate limbal stem cell procurement from eye bank donor tissue for keratolimbal allograft procedures. 
  • A flow cytometric crossmatch test using endothelial precursor cells isolated from peripheral blood. 
  • A model of sequential heart and composite tissue allotransplant in rats. 
  • A normothermic ex vivo organ perfusion delivery method for cardiac transplantation gene therapy. 
  • A novel process for optimizing musculoskeletal allograft tissue to improve safety, ultrastructural properties, and cell infiltration. 
  • A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases. 
  • A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant. 
  • A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy. 
  • A prospective longitudinal multicenter study of coagulation in pediatric patients undergoing allogeneic stem cell transplantation. 
  • A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. 
  • A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation. 
  • ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation. 
  • Abdominal sacral colpopexy with allograft fascia lata: one-year outcomes. 
  • Absence of donor MHC antigen expression ameliorates chronic kidney allograft rejection. 
  • Accelerated rejection of skin grafts in recipients sensitized with extracted human histocompatibility antigens. 
  • Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • Acute allograft rejection: cellular and humoral processes. 
  • Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. 
  • Acute graft-versus-host disease: are we close to bringing the bench to the bedside? 
  • Acute graft-vs-host disease: pathobiology and management. 
  • Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States. 
  • Acute murine cytomegalovirus disrupts established transplantation tolerance and causes recipient allo-sensitization. 
  • Addition of a second, different allogeneic graft accelerates white cell and platelet engraftment after T-cell-depleted bone marrow transplantation. 
  • Adenovirus-mediated genetic manipulation of the myocardial beta-adrenergic signaling system in transplanted hearts. 
  • Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years. 
  • Affective psychoses following renal transplant. 
  • Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates. 
  • Alemtuzumab for the prevention and treatment of graft-versus-host disease. 
  • Alimentary tract complications after renal transplantation. 
  • Allocation of vascularized composite allografts: what is it? 
  • Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia. 
  • Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis. 
  • Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty. 
  • Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial. 
  • Allogeneic Stem-Cell Transplantation - A T-Cell Balancing ACT. 
  • Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke: Clinical Outcomes from a Phase I Safety Study. 
  • Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia. 
  • Allogeneic bone marrow transplantation for treatment of severe hemolytic anemia attributable to hexokinase deficiency. 
  • Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patients. 
  • Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study. 
  • Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. 
  • Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors. 
  • Allogeneic hematopoietic stem cell transplantation is associated with cure and durable remission of late-onset primary isolated central nervous system hemophagocytic lymphohistiocytosis. 
  • Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. 
  • Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia. 
  • Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse. 
  • Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita. 
  • Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia. 
  • Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. 
  • Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis. 
  • Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease. 
  • Allogeneic marrow transplantation. 
  • Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. 
  • Allogeneic small bowel transplantation with cyclosporine and donor whole-body irradiation. 
  • Allogeneic splenocyte transfer and lipopolysaccharide inhalations induce differential T cell expansion and lung injury: a novel model of pulmonary graft-versus-host disease. 
  • Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience. 
  • Allograft Reconstruction of Chronic Tibialis Anterior Tendon Ruptures. 
  • Allograft airway fibrosis in the pulmonary milieu: a disorder of tissue remodeling. 
  • Allograft dendritic cell p40 homodimers activate donor-reactive memory CD8+ T cells. 
  • Allograft reconstruction of peroneal tendons: operative technique and clinical outcomes. 
  • Allograft reconstruction of peroneus longus and brevis tendons tears arising from a single muscular belly. Case report and surgical technique. 
  • Allografts about the Knee in Young Patients with High-Grade Sarcoma. 
  • Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide. 
  • Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival. 
  • Alterations in natural anticoagulant levels during allogeneic bone marrow transplantation: a prospective study in 27 patients. 
  • Alterations in renal interleukin-1 production during kidney transplant rejection in the rat. The effects of high-dose methylprednisolone. 
  • Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. 
  • Altered distribution of H60 minor H antigen-specific CD8 T cells and attenuated chronic vasculopathy in minor histocompatibility antigen mismatched heart transplantation in Cxcr3-/- mouse recipients. 
  • Altered intragraft immune responses and improved renal function in MHC class II-deficient mouse kidney allografts. 
  • An age-independent gene signature for monitoring acute rejection in kidney transplantation. 
  • An allogenic cell-based implant for meniscal lesions. 
  • Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. 
  • Analysis of cytokine dynamics in corneal allograft rejection. 
  • Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. 
  • Analysis of late infections in 89 long-term survivors of bone marrow transplantation. 
  • Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9. 
  • Analysis of tumor characteristics and survival in liver transplant recipients with incidentally diagnosed hepatocellular carcinoma. 
  • Anti-HLA antibodies detected in posttransplant renal allograft recipient sera correlate with chronic rejection. 
  • Anti-Leukocyte Function-Associated Antigen 1 Therapy in a Nonhuman Primate Renal Transplant Model of Costimulation Blockade-Resistant Rejection. 
  • Anti-fibrotic effects of different sources of MSC in bleomycin-induced lung fibrosis in C57BL6 male mice. 
  • Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: Does it work? 
  • Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation. 
  • Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an update. 
  • Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. 
  • Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method. 
  • Aortic valve replacement in a diseased bicuspid valve eleven years after transplantation. 
  • Apoptosis and hepatic allograft reperfusion injury. 
  • Apparent recurrence of progressive systemic sclerosis in a renal allograft. 
  • Are we ready to utilize non-heart-beating donors for clinical allotransplantation in China? 
  • Assessment of cadaveric organ viability during pulsatile perfusion using infrared imaging. 
  • Assessment of function, growth and development, and long-term quality of life after small bowel transplantation. 
  • Assessment of quality of life after pediatric intestinal transplantation by parents and pediatric recipients using the child health questionnaire. 
  • Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase. 
  • Associations between rat renal allograft function, inflammation, and host immunity. 
  • Autologous serum eye drops for severe dry eye syndrome in a patient with chronic graft-versus-host disease: a case report. 
  • Autologous transplantation for relapsed non-Hodgkin's lymphoma using intravenous busulfan and cyclophosphamide as conditioning regimen: a single center experience. 
  • Avascular necrosis of the talus: current treatment options. 
  • B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways. 
  • B cells in chronic graft-versus-host disease. 
  • B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation. 
  • BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation. 
  • BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT. 
  • BK virus and SV40 co-infection in polyomavirus nephropathy. 
  • Bacterial endocarditis caused by Oerskovia turbata. 
  • Banff Lung Report: Current knowledge and future research perspectives for diagnosis and treatment of pulmonary antibody-mediated rejection (AMR). 
  • Basiliximab decreases the incidence of acute rejection after intestinal transplantation. 
  • Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy. 
  • Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion. 
  • Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. 
  • Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation. 
  • Biomechanical comparison of figure-of-8 versus cylindrical tibial inlay constructs for arthroscopic posterior cruciate ligament reconstruction. 
  • Blocking CCL8-CCR8-Mediated Early Allograft Inflammation Improves Kidney Transplant Function. 
  • Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. 
  • Bone density loss during treatment of chronic GVHD. 
  • Bone marrow B cell precursor number after allogeneic stem cell transplantation and GVHD development. 
  • Bone marrow and thymus transplantation in ataxia-telangiectasia. 
  • Bone marrow transplantation for hematologic malignancies: the Stanford experience. 
  • Bone marrow transplantation from histocompatible sibling donors for patients with acute lymphoblastic leukemia. 
  • Bone marrow transplantation in patients aged 45 years and older. 
  • Bone marrow-derived AXL tyrosine kinase promotes mitogenic crosstalk and cardiac allograft vasculopathy. 
  • Bone-grafting in total hip replacement for acetabular protrusion. 
  • Bortezomib for effective treatment of a child with refractory autoimmune hemolytic anemia post allogeneic hematopoietic stem cell transplant. 
  • Bovine pericardium versus homologous sclera as wrapping materials for hydroxyapatite ocular implants: an animal study. 
  • Breaking the Age Barrier: Physicians' Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults. 
  • Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial. 
  • C3 complement inhibition prevents antibody-mediated rejection and prolongs renal allograft survival in sensitized non-human primates. 
  • CD154 blockade, sirolimus, and donor-specific transfusion prevents renal allograft rejection in cynomolgus monkeys despite homeostatic T-cell activation. 
  • CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation. 
  • CD62L- memory T cells enhance T-cell regeneration after allogeneic stem cell transplantation by eliminating host resistance in mice. 
  • CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire. 
  • CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. 
  • Cadaveric elbow allografts. A six-year experience. 
  • Calmodulin-dependent protein kinase IV regulates hematopoietic stem cell maintenance. 
  • Calprotectin: a novel noninvasive marker for intestinal allograft monitoring. 
  • Campath-1H in intestinal and multivisceral transplantation: preliminary data. 
  • Can We Cure Light Chain Deposition Disease of the Kidneys?-A Review and Case Report of a Patient Treated With a Triple Transplant Approach. 
  • Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds. 
  • Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility? 
  • Cardiac Allograft Vasculopathy: A Formidable Foe. 
  • Cardiopulmonary fitness in patients undergoing hematopoietic SCT: a pilot study. 
  • Cell-free DNA diagnostics in transplantation utilizing next generation sequencing. 
  • Cellular Therapies in Solid Organ Allotransplantation: Promise and Pitfalls. 
  • Cellular immunology markers postransplantation predictive of long-term graft outcome. 
  • Cellular localization and effect of nitric oxide synthesis in a rat model of orthotopic liver transplantation. 
  • Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful. 
  • Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group. 
  • Change in Anterior Cruciate Ligament Graft Choice and Outcomes Over Time. 
  • Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease. 
  • Changing trends in marrow transplantation for aplastic anemia. 
  • Chondral Lesions of the Knee: An Evidence-Based Approach. 
  • Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT. 
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology. 
  • Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. 
  • Chronic cutaneous graft-versus-host disease in man. 
  • Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. 
  • Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. 
  • Chronic kidney disease after hematopoietic cell transplantation: a systematic review. 
  • Chronic myelogenous leukemia. 
  • Chronic myelogenous leukemia. 
  • Chronic rejection of mouse kidney allografts. 
  • Class II alloantibody and mortality in simultaneous liver-kidney transplantation. 
  • Clinical and basic implications of dynamic T cell receptor clonotyping in hematopoietic cell transplantation. 
  • Clinical applications for biomarkers of acute and chronic graft-versus-host disease. 
  • Clinical experience with human anodal trypsinogen (HAT) for detection of pancreatic allograft rejection. 
  • Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities. 
  • Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients. 
  • Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI. 
  • Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin. 
  • Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases. 
  • Clinical significance of eosinophils in suspicious or borderline renal allograft biopsies. 
  • Clinical studies of hemodialysis access through formaldehyde-fixed arterial allografts. 
  • Clinical use of bone allografts in the elbow. 
  • Clinically stable human renal allografts contain histological and RNA-based findings that correlate with deteriorating graft function. 
  • Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies. 
  • Closing the gap: a novel technique for humeral shaft nonunions using cup and cone reamers. 
  • Combination chemotherapy with vincristine, cyclophosphamide, and prednisone producing long-term remission of a transplanted canine lymphoma. 
  • Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation. 
  • Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation. 
  • Combined bone allograft and adipose-derived stem cell autograft in a rabbit model. 
  • Combined medial meniscal transplantation and high tibial osteotomy. 
  • Commentary: The burning questions of reflux management in lung transplantation. 
  • Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data. 
  • Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States. 
  • Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants. 
  • Comparison of Minnesota antilymphoblast globulin and Upjohn antithymocyte globulin for induction immunosuppression of human renal allografts. 
  • Comparison of in vivo efficacy and mechanism of action of antimurine monoclonal antibodies directed against TCR alpha beta (H57-597) and CD3 (145-2C11). 
  • Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission. 
  • Comparison of the Digene Hybrid Capture System Cytomegalovirus (CMV) DNA (version 2.0), Roche CMV UL54 analyte-specific reagent, and QIAGEN RealArt CMV LightCycler PCR reagent tests using AcroMetrix OptiQuant CMV DNA quantification panels and specimens from allogeneic-stem-cell transplant recipients. 
  • Comparisons of mixed leukocyte reactions with skin graft survival in families genotyped for HL-A. 
  • Composite tissue allotransplantation: classification of clinical acute skin rejection. 
  • Composite tissue allotransplantation: current challenges. 
  • Composite tissue allotransplantation: development of a preclinical model in nonhuman primates. 
  • Composite tissue allotransplantation: past, present and future-the history and expanding applications of CTA as a new frontier in transplantation. 
  • Composite tissue transplantation: a rapidly advancing field. 
  • Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation. 
  • Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone. 
  • Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation. 
  • Cord-blood transplants from unrelated donors in Hurler's syndrome. 
  • Correction of chronic granulomatous disease after second unrelated-donor umbilical cord blood transplantation. 
  • Correction of purine nucleoside phosphorylase deficiency by transplantation of allogeneic bone marrow from a sibling. 
  • Correction of severe combined immunodeficiency by fetal liver cells. 
  • Correlation of serologic and urinary tests with allograft biopsy in the diagnosis of pancreas rejection. 
  • Correlations of test skin grafts and renal allograft function in human subjects genotyped for HL-A. 
  • Cortical strut allografts for the treatment of femoral fractures and deficiencies in revision total hip arthroplasty. 
  • Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive fungal infections in U.S. patients with graft-versus-host disease. 
  • Costimulation Blockade Resistant Rejection. 
  • Costimulation Blockade in Vascularized Composite Allotransplantation. 
  • Course of Crohn's disease after allogeneic marrow transplantation. 
  • Current and future perspectives on allogeneic transplantation using ex vivo expansion or manipulation of umbilical cord blood cells. 
  • Current and future preparative regimens for bone marrow transplantation in thalassemia. 
  • Current indications for hand and face allotransplantation. 
  • Custom, Contract, and Kidney Exchange 
  • Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival. 
  • Cytogenetic engineering in vivo: restoration of biologic complement activity to C5-deficient mice by intravenous inoculation of hybrid cells. 
  • Cytomegaloviral infection presenting as a solitary pulmonary nodule. 
  • Cytomegalovirus in Allogeneic Hematopoietic Transplantation: Impact on Costs and Clinical Outcomes Using a Preemptive Strategy. 
  • Cytomegalovirus infection presenting as bronchial polyps in lung transplant recipients. 
  • Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. 
  • DEK regulates hematopoietic stem engraftment and progenitor cell proliferation. 
  • Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies. 
  • Defective cellular immunity associated with chronic mucocutaneous moniliasis and recurrent staphylococcal botryomycosis: immunological reconstitution by allogeneic bone marrow. 
  • Dehydrated Allogenic Human Amniotic Membrane Graft for Conjunctival Surface Reconstruction Following Removal of Exposed Scleral Buckle. 
  • Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants. 
  • Depletion of host reactive T cells by photodynamic cell purging and prevention of graft versus host disease. 
  • Dermal tissue allograft for the repair of massive irreparable rotator cuff tears. 
  • Design and Patient Characteristics of the Chronic Graft-versus-Host Disease Response Measures Validation Study. 
  • Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease. 
  • Determination of the functional status of alloreactive T cells by interferon-gamma kinetics. 
  • Development and future deployment of a 5 years allograft survival model for kidney transplantation. 
  • Development of a protocol for allogeneic marrow transplantation for severe systemic sclerosis: paradigm for autoimmune disease. 
  • Development of bullous pemphigoid after allogeneic bone marrow transplantation. Report of a case. 
  • Developmental exposure to noninherited maternal antigens induces CD4+ T regulatory cells: relevance to mechanism of heart allograft tolerance. 
  • Differences in mechanisms of failure, intraoperative findings, and surgical characteristics between single- and multiple-revision ACL reconstructions: a MARS cohort study. 
  • Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders. 
  • Different roles for matrix metalloproteinase-2 and matrix metalloproteinase-9 in the pathogenesis of cardiac allograft rejection. 
  • Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection. 
  • Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors. 
  • Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease. 
  • Direct MHC class I complementary DNA transfer to thymus induces donor-specific unresponsiveness, which involves multiple immunologic mechanisms. 
  • Disaccharidase activities and fat assimilation in pediatric patients after intestinal transplantation. 
  • Dissecting the human kidney allograft transcriptome: single-cell RNA sequencing. 
  • Disseminated Nocardia caviae with positive blood cultures. 
  • Disseminated aspergillosis in a renal transplant patient: Diagnostic difficulties re-emphasized. 
  • Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes. 
  • Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic Cancers. 
  • Does recipient age impact functional outcomes of orthotopic heart transplantation? 
  • Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature. 
  • Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. 
  • Donor hepatic function: a factor in postreperfusion syndrome. 
  • Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation. 
  • Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants. 
  • Donor-reactive T-cell stimulation history and precursor frequency: barriers to tolerance induction. 
  • Double renal allografts successfully increase utilization of kidneys from older donors within a single organ procurement organization. 
  • Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. 
  • Downregulation of T cell receptor expression by CD8(+) lymphocytes in kidney allografts. 
  • Durable complete remission of acute nonlymphocytic leukemia associated with discontinuation of immunosuppression following relapse after allogeneic bone marrow transplantation. A case report of a probable graft-versus-leukemia effect. 
  • Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. 
  • ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms. 
  • Early and late interstitial pneumonia following human bone marrow transplantation. 
  • Early-onset monocyte-B-natural killer-dendritic cells' deficiency successfully treated with hematopoietic stem cell transplantation. 
  • Early-stage melanoma and hematopoietic stem cell transplantation outcomes. 
  • Editorial: Sensitization and Desensitization in Organ Transplantation. 
  • Effect of CXCL-1/KC production in high risk vascularized corneal allografts on T cell recruitment and graft rejection. 
  • Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. 
  • Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection. 
  • Effects of combined treatment with CD25- and CD154-specific monoclonal antibodies in non-human primate allotransplantation. 
  • Effects of donor splenocytes treated with mitomycin C on rat hepatic, cardiac, and intestinal allografts. 
  • Effects of murine cytomegalovirus infection on the immune response to a tumor allograft. 
  • Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival. 
  • Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. 
  • Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia model. 
  • Efficacy of a Cellular Allogeneic Bone Graft in Foot and Ankle Arthrodesis Procedures. 
  • Efficacy of a Cellular Bone Allograft for Foot and Ankle Arthrodesis and Revision Nonunion Procedures. 
  • Efficacy of signal-averaged electrocardiography in the young orthotopic heart transplant patient to detect allograft rejection. 
  • Elbow allograft for reconstruction of the elbow with massive bone loss. Long term results. 
  • Electron microscopic virus-like material in systemic lupus erythematosus: with preliminary immunologic observations on presence of measles antigen. 
  • Elevated donor hemoglobin A1c does not impair early survival in cardiac transplant recipients. 
  • Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. 
  • Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients. 
  • Endothelial graft failure after contralateral autologous corneal transplantation. 
  • Enteric conversion of bladder-drained pancreas allografts: experience in 95 patients. 
  • Epstein-Barr virus-related posttransplantation lymphoproliferative disorder involving pancreas allografts: histological differential diagnosis from acute allograft rejection. 
  • Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial. 
  • Esophageal abnormalities in chronic graft-versus-host disease in humans. 
  • Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation. 
  • Ethical issues in umbilical cord blood banking. Working Group on Ethical Issues in Umbilical Cord Blood Banking. 
  • Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study. 
  • Evidence for an immune barrier after in utero hematopoietic-cell transplantation. 
  • Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaques. 
  • Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection. 
  • Ex Vivo Expansion or Manipulation of Stem Cells to Improve Outcome of Umbilical Cord Blood Transplantation. 
  • Ex vivo characterization of human anti-porcine hyperacute cardiac rejection. 
  • Ex vivo spermine dialdehyde treatment prevents lethal GVHD in a murine bone marrow transplantation model. 
  • Exercise echocardiographic comparison of pulmonary autograft and aortic homograft replacements for aortic valve disease in adults. 
  • Exfoliative cytopathologic studies in organ transplantation IV. The cytologic diagnosis of herpesvirus in the urine of renal allograft recipients. 
  • Exfoliative cytopathologic studies in organ transplantation. 3. The cytologic profile of urine during acute renal allograft rejection. 
  • Exfoliative cytopathologic studies in organ transplantation. I. The cytologic diagnosis of cytomegalic inclusion disease in the urine of renal allograft recipients. 
  • Exfoliative cytopathologic studies in organ transplantation. V. The diagnosis of rejection in the immediate postoperative period. 
  • Experience with combined hepatic, pancreaticoduodenal, and renal procurement with UW solution. 
  • Experience with protocol biopsies after solitary pancreas transplantation. 
  • Experience with reduced-size liver transplantation in infants and children. 
  • Extended follow-up in 212 long-term allogeneic bone marrow transplant survivors. Issues of quality of life. 
  • Extracorporeal membrane oxygenation post lung transplantation. 
  • Extracorporeal membrane oxygenation support and post-heart transplant outcomes among United States adults. 
  • Extrusion of tibial tunnel bioabsorbable screw 15 months after anterior cruciate ligament reconstruction. 
  • FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. 
  • FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. 
  • Factors Influencing Graft Choice in Revision Anterior Cruciate Ligament Reconstruction in the MARS Group. 
  • Factors which have a significant effect on the survival of human skin grafts. 
  • Family-directed umbilical cord blood banking. 
  • Fanconi's anemia treated by allogeneic marrow transplantation. 
  • Fatal Apophysomyces elegans infection transmitted by deceased donor renal allografts. 
  • Fatal cytomegalovirus bronchiolitis in a patient with Nezelof's syndrome. 
  • Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005. 
  • Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation. 
  • Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors. 
  • Feasibility of renal transplantation in systemic lupus erythematosus. 
  • Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study. 
  • Female Sex Is Associated with Improved Long-Term Survival Following Allogeneic Hematopoietic Stem Cell Transplantation. 
  • Financial incentives to increase stool collection rates for microbiome studies in adult bone marrow transplant patients. 
  • Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies. 
  • Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics. 
  • Fluorescent viability stains overestimate chondrocyte viability in osteoarticular allografts. 
  • Fresh Osteochondral Allograft Transplantation for Osteochondral Lesions of the Talus: A Systematic Review. 
  • Frontiers in nephrology: immune tolerance to allografts in humans. 
  • Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency. 
  • Gamma-irradiation reduces the allogenicity of donor corneas. 
  • Gastric graft-versus-host disease: a blinded histologic study. 
  • Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. 
  • Gene Therapy for Modulation of T-Cell-Mediated Immune Response Provoked by Corneal Transplantation. 
  • Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years. 
  • Global Consensus on the Management of Limbal Stem Cell Deficiency. 
  • Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans. 
  • Graft donor selection based upon single locus (haplotype) analysis within families. 
  • Graft hyporeactivity induced by donor-derived dendritic cell progenitors. 
  • Graft hyporeactivity induced by immature donor-derived dendritic cells. 
  • Graft survival in a rhesus renal transplant model after immunotoxin-mediated T-cell depletion is enhanced by mycophenolate and steroids. 
  • Graft versus host disease following allogeneic bone marrow transplantation. 
  • Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation. 
  • Graft-versus-host disease prevention by rapamycin: cellular mechanisms. 
  • Graft-versus-host disease: allo- and autoimmunity after bone marrow transplantation. 
  • Graft-versus-leukemia in the rat--the antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease. 
  • Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation. 
  • Growth hormone accelerates immune recovery following allogeneic T-cell-depleted bone marrow transplantation in mice. 
  • Gynecological abnormalities following allogeneic bone marrow transplantation. 
  • H2-DMalpha(-/-) mice show the importance of major histocompatibility complex-bound peptide in cardiac allograft rejection. 
  • Hand transplantation in the United States: experience with 3 patients. 
  • Haploidentical transplantation for leukemia. 
  • Health-Related Quality of Life Following Allogeneic Hematopoietic Stem Cell Transplantation with Omidubicel Versus Standard Umbilical Cord Blood 
  • Hematopoietic cell transplantation for Chediak-Higashi syndrome. 
  • Hematopoietic chimerism achieved by in utero hematopoietic stem cell injection does not induce donor-specific tolerance for renal allografts in sheep. 
  • Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. 
  • Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome. 
  • Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation. 
  • Hepatic allograft-derived Kupffer cells regulate T cell response in rats. 
  • Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate. 
  • High clinical suspicion of donor-derived disease leads to timely recognition and early intervention to treat solid organ transplant-transmitted lymphocytic choriomeningitis virus. 
  • High levels of B-cell activating factor in patients with active chronic graft-versus-host disease. 
  • High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes. 
  • High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy. 
  • High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease. 
  • High-frequency alloreactive T cells augment effector function of low-frequency CD8+ T-cell responses under CD28/CD154 blockade. 
  • Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results. 
  • Homecare Encounters: An Organizational Response to Innovative Care for Patients Undergoing Hematopoietic Stem Cell Transplantation During COVID-19. 
  • Human CD4+CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance. 
  • Human FOXN1-deficiency is associated with αβ double-negative and FoxP3+ T-cell expansions that are distinctly modulated upon thymic transplantation. 
  • Human equivalent of the mouse Nude/SCID phenotype: long-term evaluation of immunologic reconstitution after bone marrow transplantation. 
  • Human interleukin-2 and lymphoproliferative (T-helper cell) responses to soluble HLA class I antigens in vitro: I. Specificity for polymorphic domains. 
  • Human monocytes as intermediaries between allogeneic endothelial cells and allospecific T cells: a role for direct scavenger receptor-mediated endothelial membrane uptake in the initiation of alloimmunity. 
  • Human renal allograft rejection despite the absence of allogeneic passenger leukocytes. 
  • Humanized anti-CD154 antibody therapy for the treatment of allograft rejection in nonhuman primates. 
  • Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution. 
  • Humoral rejection of rat hepatic transplants by passive transfer of serum. 
  • Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. 
  • Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation. 
  • Hyperbaric oxygen and cyclosporine as a combined treatment regimen to prevent skin allograft rejection in immunohistoincompatible mice. 
  • IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses. 
  • Ileocolonic perforation. A complication following renal transplantation. 
  • Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease. 
  • Immune cells in a mouse airway model of obliterative bronchiolitis. 
  • Immune competence of germ-free rats. I. Increased responsiveness to transplantation and other antigens. 
  • Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation. 
  • Immune status assay (ISA): a noninvasive procedure for studying allograft rejection. 
  • Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. 
  • Immunogenetics and transplantation. 
  • Immunogenetics of consanguineous allografts in man. I. Histocompatibility testing and skin allografts. 
  • Immunogenetics of consanguineous allografts in man. II. Correlation of renal allografting with HL-A genotyping. 
  • Immunologic chimerism as evidence of bone marrow graft acceptance in an identical twin with acute lymphocytic leukemia. 
  • Immunologic considerations in composite tissue transplantation: overview. 
  • Immunologic control of the ascites of murine adenocarcinoma 755. I. Protection with syngeneic immune serum or lymphoid cells. 
  • Immunologic resolution of human chronic graft-versus-host disease. 
  • Immunologic risks of combined kidney-pancreas transplantation. 
  • Immunological disruption of antiangiogenic signals by recruited allospecific T cells leads to corneal allograft rejection. 
  • Immunological mechanisms of allograft rejection. 
  • Immunological studies on eluates from human renal allografts. 
  • Immunology of transplantation in the central nervous system. 
  • Immunology of vascularized composite allotransplantation: a primer for hand surgeons. 
  • Immunomodulation in allogeneic marrow transplantation: use of intravenous immune globulin to suppress acute graft-versus-host disease. 
  • Immunoreconstitution. 
  • Immunosuppression without immunosuppression? How to be a tolerant individual in a dangerous world. 
  • Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft model. 
  • Immunosuppressive protocols and immunological challenges related to hand transplantation. 
  • Immunotherapy using allogeneic squamous cell tumor-dendritic cell fusion hybrids. 
  • Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection. 
  • Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome. 
  • Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease. 
  • Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study. 
  • Impact of Leukocyte Function-Associated Antigen-1 Blockade on Endogenous Allospecific T Cells to Multiple Minor Histocompatibility Antigen Mismatched Cardiac Allograft. 
  • Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. 
  • Impact of different forms of recipient antigen and different routes of antigen administration in donor pretreatment for preventing graft-versus-host disease in rat small bowel transplantation. 
  • Impact of donor cardiac arrest on heart transplantation. 
  • Impact of improving immunosuppressive treatment on outcome in cadaveric kidney transplantation. 
  • Impaired proinsulin processing is a characteristic of transplanted islets. 
  • Implementation of vascularized composite allografts in the United States: recommendations from the ASTS VCA Ad Hoc Committee and the Executive Committee. 
  • Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease. 
  • Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. 
  • Improved outcomes associated with hematopoietic stem cell transplantation for patients with juvenile myelomonocytic leukemia. 
  • Improved survival but marginal allograft function in patients treated with extracorporeal membrane oxygenation after lung transplantation. 
  • Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment. 
  • In situ and systemic cellular immunity associated with orthotopic rat liver allograft acceptance or rejection. 
  • In the face of chronic aspiration, prolonged ischemic time exacerbates obliterative bronchiolitis in rat pulmonary allografts. 
  • In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial. 
  • In vivo survival of the endothelium of freeze-stored corneal homografts in the rabbit. 
  • Incidence of anatomical variants in renal vasculature in the presence of normal renal function. 
  • Incidence, timing, and histologic grade of acute rejection in small bowel transplant recipients. 
  • Incompatible bone-marrow transplantation in lymphopenic immunologic deficiency. Circumvention of fatal graft-versus-host disease by immunologic enhancement. 
  • Increased mortality at low-volume orthotopic heart transplantation centers: should current standards change? 
  • Increased signs of acute rejection with ischemic time in a rat musculocutaneous allotransplant model. 
  • Increasing access to allotransplants in the United States: the impact of race, geography, and socioeconomics. 
  • Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. 
  • Indications and donor selections for allogeneic stem cell transplantation in children with hematologic malignancies. 
  • Induction of tolerance to parental parathyroid grafts using allogeneic thymus tissue in patients with DiGeorge anomaly. 
  • Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates. 
  • Inefficient dystrophin expression after cord blood transplantation in Duchenne muscular dystrophy. 
  • Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. 
  • Infiltrating cell phenotypes and patterns associated with hepatic allograft rejection or acceptance. 
  • Influence of gender on allograft rejection in a rat heart transplant model. 
  • Influenza Adherence Tool Kit: Implementation and Evaluation Among Allogeneic Hematopoietic Transplantation Recipients
. 
  • Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity. 
  • Inhibition of vessel allograft rejection by endothelial removal. Morphologic and ultrastructural changes. 
  • Initial experience using rapamycin immunosuppression in pediatric intestinal transplant recipients. 
  • Innate immune activation by the viral PAMP poly I:C potentiates pulmonary graft-versus-host disease after allogeneic hematopoietic cell transplant. 
  • Innate immune activation potentiates alloimmune lung disease independent of chemokine (C-X-C motif) receptor 3. 
  • Interleukin-15 receptor blockade in non-human primate kidney transplantation. 
  • International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma. 
  • Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation. 
  • Intestinal transplantation at the University of Nebraska Medical Center: 1990 to 2001. 
  • Intestinal transplantation: a single-center experience. 
  • Intestinal transplantation: the University of Wisconsin experience. 
  • Intragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusions. 
  • Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial. 
  • Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation. 
  • Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation. 
  • Iron overload and allogeneic hematopoietic stem-cell transplantation. 
  • Is it time to expand the use of cord blood donor transplantation in relapsed ALL? 
  • Isolation of a transplantable cell line induced by the MC29 avian leukosis virus. 
  • J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. 
  • Kidney transplantation using living donors. 
  • Knee osteotomy and meniscal transplantation: indications, technical considerations, and results. 
  • Knowledge about transplantation tolerance gained in primates. 
  • L-selectin is involved in lymphocyte migration to sites of inflammation in the skin: delayed rejection of allografts in L-selectin-deficient mice. 
  • LFA-1-specific therapy prolongs allograft survival in rhesus macaques. 
  • LMP-420, a small molecular inhibitor of TNF-α, prolongs islet allograft survival by induction of suppressor of cytokine signaling-1: synergistic effect with cyclosporin-A. 
  • Lack of utility of intestinal fatty acid binding protein levels in predicting intestinal allograft rejection. 
  • Lactose drives Enterococcus expansion to promote graft-versus-host disease. 
  • Large fresh osteochondral allografts of the knee: a systematic clinical and basic science review of the literature. 
  • Late complications of allogeneic and autologous marrow transplantation. 
  • Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors. 
  • Late graft loss and long-term outcome after isolated intestinal transplantation in children. 
  • Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. 
  • Late traumatic wound rupture following successful partial penetrating keratoplasty. 
  • Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. 
  • Liver and intestine transplantation in the United States 1998-2007. 
  • Liver and intestine transplantation in the United States, 1997-2006. 
  • Living-unrelated renal transplantation at the University of Wisconsin. 
  • Local complications after limb-salvage surgery for pediatric bone tumours: a pictorial essay. 
  • Localization of functionally different guinea-pig spleen cells in albumin gradients. 
  • Long-Term Follow-up of CALGB (Alliance) 100001: Autologous Followed by Nonmyeloablative Allogeneic Transplant for Multiple Myeloma. 
  • Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia. 
  • Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells. 
  • Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin. 
  • Long-term outcome after marrow transplantation for severe aplastic anemia. 
  • Long-term outcomes and quality of life after intestine transplantation. 
  • Long-term outcomes in simultaneous kidney-pancreas transplantation. 
  • Long-term results with forty-five living related renal allograft recipients genotypically identical for HLA. 
  • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. 
  • Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. 
  • Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism. 
  • Long-term survival following kidney transplantation in previous lung transplant recipients-An analysis of the unos registry. 
  • Long-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes. 
  • Long-term tolerance to allogeneic thymus transplants in complete DiGeorge anomaly. 
  • Longitudinal analysis of T-cell receptor variable beta chain repertoire in patients with acute graft-versus-host disease after allogeneic stem cell transplantation. 
  • Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients. 
  • Lung allograft standardized histological analysis (LASHA) template: A research consensus proposal. 
  • Lung transplant metalloproteinase levels are elevated prior to bronchiolitis obliterans syndrome. 
  • Lung transplantation delays gastric motility in patients without prior gastrointestinal surgery-A single-center experience of 412 consecutive patients. 
  • Lymphopenic immunologic deficiency in identical twins: lymphocyte allografting and graft-versus-host disease following treatment with albumin-gradient-separated paternal bone marrow cells. 
  • Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies. 
  • Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006). 
  • Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. 
  • Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study. 
  • Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. 
  • Marrow transplantation for malignant plasma cell disorders: summary of the Seattle experience. 
  • Marrow transplantation for severe aplastic anemia and thalassemia major. 
  • Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. 
  • Mechanisms of tolerance induced by PG490-88 in a bone marrow transplantation model. 
  • Mechanisms of tolerance induced by an immunotoxin against CD3 epsilon in a rhesus kidney allograft model. 
  • Mechanisms of tolerance to parental parathyroid tissue when combined with human allogeneic thymus transplantation. 
  • Meeting Report of the 13th Congress of the International Society of Vascularized Composite Allotransplantation. 
  • Membranoproliferative glomerulonephritis. Progression from the pure form to the crescentic form with recurrence after transplantation. 
  • Memory T-cell-specific therapeutics in organ transplantation. 
  • Meniscal allograft transplantation. Part 1: systematic review of graft biology, graft shrinkage, graft extrusion, graft sizing, and graft fixation. 
  • Meniscal allograft transplantation. Part 2: systematic review of transplant timing, outcomes, return to competition, associated procedures, and prevention of osteoarthritis. 
  • Meniscal allograft transplantation: a systematic review. 
  • Meniscus transplantation: current concepts. 
  • Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. 
  • Methods to prevent rejection of homografts in man: a report on living related kidney donor selection by HL-A genotyping. 
  • Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. 
  • Microvascular inflammation in renal allograft biopsies assessed by endothelial and leukocyte co-immunostain: a retrospective study on reproducibility and clinical/prognostic correlates. 
  • Midterm results of osteochondral lesions of the talar shoulder treated with fresh osteochondral allograft transplantation. 
  • Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia. 
  • Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. 
  • Molecular characterization of hypoxia-hypothermia-conditioned human endothelial cells and their interaction with human monocytes. 
  • Molecular epidemiologic evaluation of endocarditis due to Oerskovia turbata and CDC group A-3 associated with contaminated homograft valves. 
  • Molecular evaluation of BK polyomavirus nephropathy. 
  • Monocyte infiltration and kidney allograft dysfunction during acute rejection. 
  • Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model. 
  • Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant. 
  • Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study. 
  • Mycobacterial pulmonary infections after allogeneic bone marrow transplantation. 
  • Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes. 
  • Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease. 
  • Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial. 
  • Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation. 
  • Myelodysplastic syndromes: clinical practice guidelines in oncology. 
  • Myocardial acoustics in pediatric allograft rejection. 
  • NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022. 
  • NCCN Practice Guidelines for Chronic Myelogenous Leukemia. 
  • NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: state of the science, future directions. 
  • Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation. 
  • Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation. 
  • Neointimal inflammation and adventitial angiogenesis correlate with severity of cardiac allograft vasculopathy in pediatric recipients. 
  • Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. 
  • New developments in allotransplant immunology. 
  • No change in complication rate using spring-loaded gun compared to traditional percutaneous renal allograft biopsy techniques. 
  • Non-HLA antibodies in transplantation: when do they matter? 
  • Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation. 
  • Non-myeloablative umbilical cord blood transplantation. 
  • Nonhuman primates for the study of composite tissue allotransplantation. 
  • Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. 
  • Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. 
  • Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice. 
  • Novel Scoring Criteria for the Evaluation of Ocular Graft-versus-Host Disease in a Preclinical Allogeneic Hematopoietic Stem Cell Transplantation Animal Model. 
  • Operational immune tolerance towards transplanted allogeneic pancreatic islets in mice and a non-human primate. 
  • Optimizing PLG nanoparticle-peptide delivery platforms for transplantation tolerance using an allogeneic skin transplant model. 
  • Options for digital nerve gap. 
  • Oral beclomethasone therapy for recurrent small bowel allograft rejection and intestinal graft-versus-host disease. 
  • Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients. 
  • Orthopedic complications of renal transplantation in children. 
  • Osteochondral allograft of the talus. 
  • Osteochondral talar allograft for large osteochondral defects: technique tip. 
  • Outcome after splenic vein thrombosis in the pancreas allograft. 
  • Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome. 
  • Outcomes in bicaval versus biatrial techniques in heart transplantation: an analysis of the UNOS database. 
  • Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression. 
  • Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation. 
  • Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection. 
  • Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. 
  • Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma. 
  • Overcoming Chronic Rejection-Can it B? 
  • PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue. 
  • PG27, an extract of Tripterygium wilfordii hook f, induces antigen-specific tolerance in bone marrow transplantation in mice. 
  • PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE Trial. 
  • Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial. 
  • Pancreatic islet transplantation using the nonhuman primate (rhesus) model predicts that the portal vein is superior to the celiac artery as the islet infusion site. 
  • Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease. 
  • Partial heart transplantation for pediatric heart valve dysfunction: A clinical trial protocol. 
  • Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution. 
  • Particulated juvenile articular cartilage allograft transplantation for osteochondral lesions of the knee and ankle. 
  • Pathophysiologic mechanisms of acute graft-vs.-host disease. 
  • Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications. 
  • Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. 
  • Pediatric Acute Respiratory Distress Syndrome in Pediatric Allogeneic Hematopoietic Stem Cell Transplants: A Multicenter Study. 
  • Perforation of the gastrointestinal tract following renal transplantation. 
  • Peripheral blood allogeneic microchimerism in lung and cardiac allograft recipients. 
  • Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions. 
  • Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway. 
  • Pharmacokinetics and biochemical efficacy of pirmagrel, a thromboxane synthase inhibitor, in renal allograft recipients. 
  • Phase I/II Trial of Dose-Escalated Busulfan Delivered by Prolonged Continuous Infusion in Allogeneic Transplant Patients. 
  • Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502. 
  • Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors. 
  • Phenotype and patterns of inflammatory cell infiltration associated with rejection or acceptance of rat liver allografts. 
  • Piceatannol in combination with low doses of cyclosporine A prolongs kidney allograft survival in a stringent rat transplantation model. 
  • Pitfalls and Successes in Trials in Older Transplant Patients with Hematologic Malignancies. 
  • Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease. 
  • Platelet-derived CD154: ultrastructural localization and clinical correlation in organ transplantation. 
  • Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154. 
  • Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells. 
  • Polymyositis as a manifestation of chronic graft-versus-host disease. 
  • Positive serum cryoglobulin is associated with worse outcome after liver transplantation for chronic hepatitis C. 
  • Possible production of immunosuppression in the host by exposure to microorganisms: observations in germfree rats. 
  • Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease. 
  • Potential of costimulation-based therapies for composite tissue allotransplantation. 
  • Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: Multicenter survey of transplant centers in the United States. 
  • Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation. 
  • Pre-transplant Screening for Non-HLA Antibodies: Who should be Tested? 
  • Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality. 
  • Predicting outcome of procedures to slow intestinal transit. 
  • Predictors of Older Donor Lung Use: Are We Too Good at Saying No? 
  • Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. 
  • Preemptive Tolerogenic Delivery of Donor Antigens for Permanent Allogeneic Islet Graft Protection. 
  • Preoperative urodynamic evaluation may predict voiding dysfunction in women undergoing pubovaginal sling. 
  • Preservation of the cadaveric kidney for transplantation. 
  • Pretransplant antithymocyte globulin has increased efficacy in controlling donor-reactive memory T cells in mice. 
  • Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes. 
  • Prevalence of nutrition-related problems among long-term survivors of allogeneic marrow transplantation. 
  • Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation. 
  • Prevention of GVHD without losing GVL effect: windows of opportunity. 
  • Prevention of allograft rejection by amplification of Foxp3(+)CD4(+)CD25(+) regulatory T cells. 
  • Prevention of autoimmune islet allograft destruction by engraftment of donor T cells. 
  • Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation. 
  • Primary vascularization of the graft determines the immunodominance of murine minor H antigens during organ transplantation. 
  • Primate skin allotransplantation with anti-CD154 monotherapy. 
  • Proceedings: Immunologic similarities between fetal cell antigens and tumor cell antigens in guinea pigs. 
  • Progress in graft-versus-host disease. 
  • Prolonged survival of class II transactivator-deficient cardiac allografts. 
  • Properties of prostatic cultures transformed by SV40. 
  • Prospective Evaluation of Structural Allograft Transplantation for Osteochondral Lesions of the Talar Shoulder. 
  • Prospective, Multicenter Evaluation of Allogeneic Bone Matrix Containing Viable Osteogenic Cells in Foot and/or Ankle Arthrodesis. 
  • Pubovaginal sling using cadaveric allograft fascia for the treatment of intrinsic sphincter deficiency. 
  • Pulmonary Complications in Pediatric and Adolescent Patients Following Allogeneic Hematopoietic Cell Transplantation. 
  • Quantitative cardiac magnetic resonance T2 imaging offers ability to non-invasively predict acute allograft rejection in children. 
  • Rabbit antithymocyte globulin induction and sirolimus monotherapy supports prolonged islet allograft function in a nonhuman primate islet transplantation model. 
  • Radiation disasters: role of the BMT team. 
  • Radical anterior segment surgery for epithelial invasion of the anterior chamber: report of three cases. 
  • Radiographic and clinical outcomes following single-level anterior cervical discectomy and allograft fusion without plate placement or cervical collar. 
  • Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. 
  • Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. 
  • Rapamycin suppression of host-versus-graft and graft-versus-host disease in MHC-mismatched rats. 
  • Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia. 
  • Rapid translocation of bacteria in small bowel transplantation. 
  • Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty. 
  • Re-innervation of ganglia transplanted to the neck from different levels of the guinea-pig sympathetic chain. 
  • Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease. 
  • Recent advances in immunosuppressive therapy for prevention of renal allograft rejection. 
  • Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection. 
  • Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease. 
  • Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. 
  • Recovery of in vivo cellular immunity after human marrow grafting. Influence of time postgrafting and acute graft-versus-host disease. 
  • Recruitment of Donor T Cells to the Eyes During Ocular GVHD in Recipients of MHC-Matched Allogeneic Hematopoietic Stem Cell Transplants. 
  • Recruitment of host progenitor cells in rat liver transplants. 
  • Recurrent acute inflammatory demyelinating polyradiculitis after allogeneic bone marrow transplantation. 
  • Reduced antigenicity of formaldehyde-fixed arterial allografts and their potential clinical application. 
  • Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts. 
  • Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901. 
  • Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies. 
  • Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002). 
  • Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation. 
  • Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells. 
  • Rejection of canine cardiac allografts. 
  • Rejection of kidney allografts by MHC class I-deficient mice. 
  • Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. 
  • Renal allograft cell infiltrates associated with irreversible rejection. 
  • Renal allograft-infiltrating lymphocytes. A prospective analysis of in vitro growth characteristics and clinical relevance. 
  • Renal allografts in HL-A matched recipients. Light, immunofluorescence and electron microscopic studies. 
  • Renal transplantation between HL-A haploidentical donor-recipient pairs: functional and morphological evaluation. 
  • Renal transplantation between HL-A identical donor-recipient pairs. Functional and morphological evaluation. 
  • Renal transplantation between histocompatible donor-recipient pairs. 
  • Renin-angiotensin system gene expression in post-transplant hypertension predicts allograft function. 
  • Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). 
  • Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection. 
  • Results of isolated acetabular revisions: the fate of the unrevised femoral component. 
  • Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. 
  • Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. 
  • Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. 
  • Retransplantation in the diabetic with a pancreas allograft after previous kidney or pancreas transplant. 
  • Return to Sport Activity After Meniscal Allograft Transplantation: At What Level and at What Cost? A Systematic Review and Meta-analysis. 
  • Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States. 
  • Reversal of acute allograft rejection using immunotoxin. 
  • Reversal of chlorpyrifos neurobehavioral teratogenicity in mice by allographic transplantation of adult subventricular zone-derived neural stem cells. 
  • Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. 
  • Review of chronic graft-versus-host disease in children after allogeneic stem cell transplantation: nursing perspective. 
  • Risk Factors and Predictors of Significant Chondral Surface Change From Primary to Revision Anterior Cruciate Ligament Reconstruction: A MOON and MARS Cohort Study. 
  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation. 
  • Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. 
  • Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial. 
  • Role of CCR7 in facilitating direct allosensitization and regulatory T-cell function in high-risk corneal transplantation. 
  • Role of Fresh Osteochondral Allografts for Large Talar Osteochondral Lesions. 
  • Role of T cell recruitment and chemokine-regulated intra-graft T cell motility patterns in corneal allograft rejection. 
  • Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution. 
  • Safety and Efficacy of Allogeneic Lung Spheroid Cells in a Mismatched Rat Model of Pulmonary Fibrosis. 
  • Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients. 
  • Science of composite tissue allotransplantation. 
  • Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome. 
  • Second marrow infusion for poor graft function after allogeneic marrow transplantation. 
  • Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation. 
  • Secondary failure of platelet recovery after hematopoietic stem cell transplantation. 
  • Secondary lymphoid tissue and costimulation-blockade resistant rejection: A nonhuman primate renal transplant study. 
  • Selection of donors for kidney transplantation. 
  • Selection of patients with Hodgkin's disease and non-Hodgkin's lymphoma for bone marrow transplantation. 
  • Selective bowel decontamination in hospitalized patients awaiting liver transplantation. 
  • Selective elimination of alloreactivity from immunotherapeutic T cells by photodynamic cell purging and memory T-cell sorting. 
  • Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma. 
  • Short-term and intermediate-term outcomes of aortic root replacement with St. Jude mechanical conduits and aortic allografts. 
  • Should abdominal cluster transplantation be abandoned? 
  • Significance of and risk factors for the development of central airway stenosis after lung transplantation. 
  • Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection. 
  • Simultaneous bilateral lung and pancreas transplantation in recipient with cystic fibrosis. 
  • Simultaneous pancreas-kidney (SPK) transplantation from controlled non-heart-beating donors (NHBDs). 
  • Single cell transcriptomics of mouse kidney transplants reveals a myeloid cell pathway for transplant rejection. 
  • Skin graft rejection between subjects genotyped for HL-A. 
  • Spermine dialdehyde, a novel ex vivo purging agent for both allogenic and autologous bone marrow transplantations. 
  • Split tolerance induced by immunotoxin in a rhesus kidney allograft model. 
  • Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy. 
  • Stem cell transplantation for multiple myeloma. 
  • Stem-cell transplantation for sickle cell disease. 
  • Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen. 
  • Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients. 
  • Successful formation of a chimeric human thymus allograft following transplantation of cultured postnatal human thymus. 
  • Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. 
  • Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status. 
  • Surgical Techniques for Revascularization in Abdominal Wall Transplantation. 
  • Surgical transplant physical examination: correlation of renal resistance index and biopsy-proven chronic allograft nephropathy. 
  • Survival after HLA-identical allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: meta-analysis of randomized controlled trials. 
  • Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis. 
  • Survival following allogeneic transplant in patients with myelofibrosis. 
  • Survival of allografted pancreatic islets in the subretinal space in rats. 
  • Survival of subretinal pancreatic islet cell allografts and apoptosis in infiltrating lymphocytes in rats. 
  • Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study. 
  • Symptomatic pulmonary allograft Kaposi's sarcoma in two lung transplant recipients. 
  • Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. 
  • T-Cell recovery in adults and children following umbilical cord blood transplantation. 
  • Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study. 
  • Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation. 
  • Targeting Calcium Release-activated Calcium Channel Is Not Sufficient to Prevent Rejection in Nonhuman Primate Kidney Transplantation. 
  • Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells. 
  • Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation. 
  • Textbook Outcome: Definition and Analysis of a Novel Quality Measure in Lung Transplantation. 
  • The Banff 2007 working classification of skin-containing composite tissue allograft pathology. 
  • The Clinical Impact of Non-HLA Antibodies in Solid Organ Transplantation. 
  • The Development and Early to Midterm Findings of the Multicenter Revision Anterior Cruciate Ligament Study. 
  • The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. 
  • The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques. 
  • The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success. 
  • The anterior cruciate ligament and arthritis. 
  • The azaspirane SKF 105685 ameliorates renal allograft rejection in rats. 
  • The biomechanical effects of 1.0 to 1.2 Mrad of γ irradiation on human bone-patellar tendon-bone allografts. 
  • The clinical application of monoclonal antibody therapies in renal transplantation. 
  • The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge. 
  • The current status of laser usage in ophthalmology. 
  • The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation. 
  • The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID). 
  • The effect of pretreatment with class I major histocompatibility complex (MHC) antigens on hepatic or cardiac allograft survival in the rat. 
  • The effector component of the cytotoxic T-lymphocyte response has a biphasic pattern after burn injury. 
  • The effects of donor-specific blood transfusion enhancement of rat renal allografts on host NK cell responses. 
  • The fetal allograft revisited: does the study of an ancient invertebrate species shed light on the role of natural killer cells at the maternal-fetal interface? 
  • The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. 
  • The histological effect of barrier vein wrapping of peripheral nerves. 
  • The history of human composite tissue allotransplantation. 
  • The immunogenetics of the major histocompatibility chromosomal region in man. 
  • The incidence and management of pulmonary mycosis in renal allograft patients. 
  • The influence of dose and dose rate of total lymphoid irradiation in the rat cardiac allograft model. 
  • The natural history of renal function following orthotopic heart transplant. 
  • The need for inducing tolerance in vascularized composite allotransplantation. 
  • The rehabilitation of renal allograft recipients. 
  • The relationship of transfusion and presensitization with graft and patient survival. 
  • The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials. 
  • The role of RT1.a major histocompatibility antigens in prolonging the survival of hepatic allografts in the rat. 
  • The role of adenotonsillectomy in graft-versus-host disease. 
  • The role of class I antigens in hyperacute rejection of hepatic allografts in rats. 
  • The role of human T cells in human anti-pig xenogeneic cellular responses. 
  • The role of innate immunity in acute allograft rejection after lung transplantation. 
  • The role of soluble and insoluble gastric fluid components in the pathogenesis of obliterative bronchiolitis in rat lung allografts. 
  • The source of murine cytomegalovirus in mice receiving kidney allografts. 
  • The use of autologous adult, allogenic juvenile, and combined juvenile-adult cartilage fragments for the repair of chondral defects. 
  • The use of bilateral adult renal allografts - a method to optimize function from donor kidneys with suboptimal nephron mass. 
  • The use of local allograft irradiation following renal transplantation. 
  • Therapeutic angiography in renal transplant complications. 
  • Thrombocytopenia in allogeneic peripheral blood stem cell collections. 
  • Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras. 
  • Thymus transplantation for complete DiGeorge syndrome: European experience. 
  • Thymus transplantation. 
  • To D or not to D: vitamin D in hematopoietic cell transplantation. 
  • Tolerance and the "Holy Grail" of transplantation. 
  • Total lymphoid irradiation and cyclosporine prolongs cardiac allograft survival in the sensitized rat model. 
  • Toxicity, pharmacology and feasibility of administration of PEG-L-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemia. 
  • Transplant outcomes in mucopolysaccharidoses. 
  • Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research. 
  • Transplantation in miniature swine. 
  • Transplantation in miniature swine. II. In vitro parameters of histocompatibility in MSLA homozygous minipigs. 
  • Transplantation in miniature swine. III: effects of MSLA and A-O blood group matching on skin allograft survival. 
  • Transplantation in miniature swine. VI. Factors influencing survival of renal allografts. 
  • Transplantation of a child with sickle cell anemia with an unrelated cord blood unit after reduced intensity conditioning. 
  • Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. 
  • Transplantation of the hand, face, and composite structures: evolution and current status. 
  • Transplantation of the parathyroid glands in man: clinical indications and results. 
  • Transplantation without pretransplant therapy: Is this a possibility? Insights into providing transplantation at diagnosis for patients with acute leukemia. 
  • Transplanted carcinoma in an immunosuppressed patient. 
  • Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine. 
  • Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor. 
  • Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival. 
  • Treatment of intestinal failure: intestinal transplantation. 
  • Treatment of non-Hodgkin's lymphoma with chemoradiotherapy and allogenic marrow transplantation. 
  • Treatment of non-Hodgkin's lymphoma with high-dose therapy and hematopoietic stem cell support. 
  • Treatment with Foscarnet after Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Is Associated with Long-Term Loss of Renal Function. 
  • Treatment with immunotoxin. 
  • Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates. 
  • Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. 
  • Tumor resistance in rats immunized to fetal tissues. 
  • Type 2 angiotensin II receptor expression in human renal allografts: an association with chronic allograft nephropathy. 
  • Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT). 
  • Unaltered graft survival and intragraft lymphocytes infiltration in the cardiac allograft of Cxcr3-/- mouse recipients. 
  • Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis. 
  • Unique aspects of rejection and tolerance in liver transplantation. 
  • Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection. 
  • Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia. 
  • Unrelated donor marrow transplantation in children. 
  • Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection. 
  • Urologic complications in renal transplantation. 
  • Urologic complications in renal transplantation. 
  • Urologic morbidity in renal transplantation. 
  • Urologic surgery. 
  • Urological complications and vesicoureteral reflux following pediatric kidney transplantation. 
  • Use of OKT3 in kidney, pancreas, and liver transplantation. 
  • Use of allograft biopsies to assess thymopoiesis after thymus transplantation. 
  • Use of lung allografts from brain-dead donors after cardiopulmonary arrest and resuscitation. 
  • Use of vascularized posterior rectus sheath allograft in pediatric multivisceral transplantation--report of two cases. 
  • Utility of Autopsy among Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients: One Last Chance to Learn? 
  • Utilization and tailoring of interventional radiology procedures in small bowel transplants. 
  • Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation. 
  • Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease. 
  • Variance in Anterior Cruciate Ligament Reconstruction Graft Selection based on Patient Demographics and Location within the Multicenter Orthopaedic Outcomes Network Cohort. 
  • Vascularized Composite Allotransplantation: A Functional Hind Limb Model in Mice. 
  • Vascularized composite allotransplantation at a crossroad. 
  • Vascularized composite allotransplantation research: the emerging field. 
  • Vascularized composite allotransplantation: a closer look at the banff working classification. 
  • Viral infection abrogates CD8(+) T-cell deletion induced by costimulation blockade. 
  • Viral infection-homograft interactions in a murine model. 
  • What do we really know about allografts? 
  • What's new--what's hot in basic science: American Transplant Congress 2004. 
  • Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program. 
  • Xenoreactive natural antibodies and isohemagglutinins: a distinct class of antibodies. 
  • [Enhanced immune reaction of germ-free rats after skin allotransplantation]. 
  • epsilon-Aminocaproic acid plasma levels during cardiopulmonary bypass. 
• 

  Keywords of People

  • Chen, Jun, Professor of Medicine, Duke Cancer Institute
  • Cianciolo, George James, Associate Professor Emeritus of Pathology, Pathology
  • Knechtle, Stuart Johnston, William R. Kenan, Jr. Distinguished Professor, Medicine, Nephrology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Routh, Jonathan Charles, Paul H. Sherman, M.D. Distinguished Associate Professor of Surgery, Pediatrics
  • Tsalik, Ephraim, Adjunct Associate Professor in the Department of Medicine, Medicine, Infectious Diseases
  • Weinhold, Kent James, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Integrative Immunobiology